AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home Precision Radiation Oncology Article
Article Link
Cite
EndNote(RIS) BibTeX
Collect
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Clinical Guideline | Open Access

Clinical Guidelines for the Prevention and Treatment of Radiation-induced Bladder Injury

Weiping Wang1,2, Fuquan Zhang1,2,3,4 ( ), Shuanghu Yuan2,3,4,5 ( )
Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Dongcheng-qu, Beijing, China
Chinese Radiation Therapy Oncology Group
China Anti-Cancer Association Tumor Support Therapy Committee
China Anti-Cancer Association Tumor Radiation Protection Committee
Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China
Show Author Information

Abstract

Radiation-induced bladder injury is a common complication after pelvic radiotherapy. Few studies exist on diagnosing and treating radiation-induced bladder injury, with no established guidelines or consensus in China or internationally. Clinical physicians’ diagnosis and treatment of radiation-induced bladder injury are primarily based on their own clinical experience, and there is an urgent need for unified guidelines to standardize clinical diagnosis and treatment. Therefore, the Chinese Radiation Therapy Oncology Group, China Anti-Cancer Association Tumor Support Therapy Committee, and China Anti-Cancer Association Tumor Radiation Protection Committee gathered experts to develop Chinese clinical practice guidelines, guiding diagnosing and treating radiation-induced bladder injury. The development of these guidelines adopted the grading system of evidence quality and recommendation strength (GRADE).

Keywords

TreatmentClinical practice guidelinesRadiation-induced bladder injuryRadiation cystitis

References

1

Guyatt G, Oxman AD, Akl EA, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383-394.
Crossref Google Scholar
2

Francolini G, Detti B, Becherini C, et al. Toxicity after moderately hypofractionated versus conventionally fractionated prostate radiotherapy: a systematic review and meta-analysis of the current literature. Crit Rev Oncol Hematol. 2021;165: 103432
Crossref Google Scholar
3

Kerkmeijer LGW, Groen VH, Pos FJ, et al. Focal boost to the intraprostatic tumor in external beam radiotherapy for patients with localized prostate cancer: results from the FLAME randomized phase Ⅲ trial. J Clin Oncol. 2021;39(7):787–796.
Crossref Google Scholar
4

Di Franco R, Borzillo V, Ravo V, et al. Rectal/urinary toxicity after hypofractionated vs. conventional radiotherapy in high risk prostate cancer: systematic review and meta analysis. Eur Rev Med Pharmacol Sci. 2017;21(16):3563–3575.
Google Scholar
5

Kirwan JM, Symonds P, Green JA, et al. A systematic review of acute and late toxicity of concomitant chemoradiation for cervical cancer. Radiat Oncol. 2003;68(3):217–226.
Crossref Google Scholar
6

Gilbert A, Ziegler L, Martland M, et al. Systematic review of radiation therapy toxicity reporting in randomized controlled trials of rectal cancer: a comparison of patient-reported outcomes and clinician toxicity reporting. Int J Radiat Oncol Biol Phys. 2015;92(3):555–567.
Crossref Google Scholar
7

Maduro JH, Pras E, Willemse PH, et al. Acute and long-term toxicity following radiotherapy alone or in combination with chemotherapy for locally advanced cervical cancer. Cancer Treat Rev. 2003;29(6):471–488.
Crossref Google Scholar
8

Potter R, Tanderup K, Schmid MP, et al. MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study. Lancet Oncol. 2021;22(4):538–547.
Crossref Google Scholar
9

Brossard C, Lefranc AC, Simon JM, et al. Understanding molecular mechanisms and identifying key processes in chronic radiation cystitis. Int J Mol Sci. 2022;23(3):1836.
Crossref Google Scholar
10

Jaal J, Dorr W. Radiation-induced damage to mouse urothelial barrier. Radiat Oncol. 2006;80(2):250–256.
Crossref Google Scholar
11

El-Benhawy SA, Sadek NA, Kamel MM, et al. Study the relationship of endothelial damage /dysfunction due to occupational exposure to low dose ionizing radiation versus high dose exposure during radiotherapy. Cancer Treat Res Commun. 2020;25:100215.
Crossref Google Scholar
12
Helissey C, Cavallero S, Brossard C, Dusaud M, Chargari C, François S. Chronic Inflammation and Radiation-Induced Cystitis: Molecular Background and Therapeutic Perspectives. Cells. 2020;10(1):21. Published 2020 Dec 24. doi: 10.3390/cells10010021
Crossref
13

Jaal J, Bruchner K, Hoinkis C, et al. Radiation-induced variations in urothelial expression of intercellular adhesion molecule 1 (ICAM-1): association with changes in urinary bladder function. Int J Radiat Biol. 2004;80(1):65–72.
Crossref Google Scholar
14

Jaal J, Dorr W. Radiation induced inflammatory changes in the mouse bladder: the role of cyclooxygenase-2. J Urol. 2006;175(4):1529–1533.
Crossref Google Scholar
15

Zwaans BM, Nicolai HG, Chancellor MB, et al. Challenges and opportunities in radiation-induced hemorrhagic cystitis. Rev Urol. 2016;18(2):57–65.
Google Scholar
16

Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer(EORTC). Int J Radiat Oncol Biol Phys. 1995;31(5):1341–1346.
Crossref Google Scholar
17

Harsolia A, Vargas C, Yan D, et al. Predictors for chronic urinary toxicity after the treatment of prostate cancer with adaptive three-dimensional conformal radiotherapy: dose-volume analysis of a phase Ⅱ dose-escalation study. Int J Radiat Oncol Biol Phys. 2007;69(4):1100–1109.
Crossref Google Scholar
18

Inokuchi H, Mizowaki T, Norihisa Y, et al. Correlation between urinary dose and delayed radiation cystitis after 78 Gy intensity-modulated radiotherapy for high-risk prostate cancer: a 10-year follow-up study of genitourinary toxicity in clinical practice. Clin Transl Rad Oncol. 2017;6:31–36.
Crossref Google Scholar
19

Michalski JM, Yan Y, Watkins-Bruner D, et al. Preliminary toxicity analysis of 3-dimensional conformal radiation therapy versus intensity modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group 0126 prostate cancer trial. Int J Radiat Oncol Biol Phys. 2013;87(5):932–938.
Crossref Google Scholar
20

Eifel PJ, Jhingran A, Bodurka DC, et al. Correlation of smoking history and other patient characteristics with major complications of pelvic radiation therapy for cervical cancer. J Clin Oncol. 2002, 20(17):3651–3657.
Crossref Google Scholar
21

Viswanathan AN, Yorke ED, Marks LB, et al. Radiation dose-volume effects of the urinary bladder. Int J Radiat Oncol Biol Phys. 2010;76(3 Suppl):116-122.
Crossref Google Scholar
22

Vanneste BGL, Van Limbergen EJ, Marcelissen TA, et al. Development of a management algorithm for acute and chronic radiation urethritis and cystitis. Urol Int. 2022;106(1):63–74.
Crossref Google Scholar
23

Payne H, Adamson A, Bahl A, et al. Chemical-and radiation-induced haemorrhagic cystitis: current treatments and challenges. BJU Int. 2013;112(7):885–897.
Crossref Google Scholar
24

Chen Y, Wang Y, Kong F, et al. CBCT was used to analyze the positioning error of radiotherapy for 50 cases of pelvic malignant tumor [J. Chin J Cancer Prev Treat. 2019;26(18):1382–1386.
Google Scholar
25

Arbea L, Ramos LI, Martinez-Monge R, et al. Intensity-modulated radiation therapy (IMRT) vs. 3D conformal radiotherapy (3DCRT) in locally advanced rectal cancer (LARC): dosimetric comparison and clinical implications. Radiat Oncol. 2010;5:17
Crossref Google Scholar
26

Chinese Society of Radiation Oncology, Chinese Medical Association Radiation Oncology Branch, Chinese Anti-Cancer Association Radiation Oncology Professional Committee. Chinese guidelines for radiotherapy of prostate cancer (2020 version). Chines J Cancer Prev Treat. 2021;28(5):323–337.
Crossref Google Scholar
27

Chinese Society of Radiation Oncology, Chinese Medical Association Radiation Oncology Branch, Chinese Anti-Cancer Association Radiation Oncology Professional Committee. Chinese guidelines for radiotherapy of rectal cancer (2020 version). Int J Oncol. 2021;48(7):389-401.
Google Scholar
28

The Brachytherapy Group of China Society for Radiation Oncology, The Gynecological Oncology Group of Chinese Association for Therapeutic Radiation Oncologists, The Brachytherapy Special Committee of Chinese Anti-Cancer Association. Chinese expert consensus on three-dimensional image guided brachytherapy for cervical cancer. Radiat Oncol J. 2020;29(9):712–717
Google Scholar
29

Vanni G, Pellicciaro M, Materazzo M, et al. Advanced stages and increased need for adjuvant treatments in breast cancer patients: the effect of the one-year COVID-19 pandemic. Anticancer Res. 2021;41(5):2689–2696
Crossref Google Scholar
30

Smit SG, Heyns CF. Management of radiation cystitis. Nat Rev Urol. 2010;7(4):206–214
Crossref Google Scholar
31

Goswami AK, Mahajan RK, Nath R, et al. How safe is 1% alum irrigation in controlling intractable vesical bleeding? J Urol. 1993;149(2):264–267.
Crossref Google Scholar
32

Arrizabalaga M, Extramiana J, Parra JL, et al. Treatment of massive haematuria with aluminous salts. Brit J Urol. 1987;60(3):223–226.
Crossref Google Scholar
33

Phelps KR, Naylor K, Brien TP, et al. Encephalopathy after bladder irrigation with alum: case report and literature review. Am J Med Sci. 1999;318(3):181–185.
Crossref Google Scholar
34

Alfrey AC. Aluminum toxicity in patients with chronic renal failure. Ther Drug Monit. 1993;15(6):593–597
Crossref Google Scholar
35

Pascoe C, Duncan C, Lamb BW, et al. Current management of radiation cystitis: a review and practical guide to clinical management. BJU Int. 2019;123(4):585–594
Crossref Google Scholar
36

Ziegelmann MJ, Boorjian SA, Joyce DD, et al. Intravesical formalin for hemorrhagic cystitis: a contemporary cohort. Can Urol Assoc J. 2017, 11(3-4):E79-E82.
Crossref Google Scholar
37

Wu S, Lan M. Local use of rhGM-CSF for the treatment of chemoradiotherapy induced oral mucositis. Drug Evaluation. 2012;9(30):4–7
Google Scholar
38

Vela-Ojeda J, Tripp-Villanueva F, Sanchez-Cortes E, et al. Intravesical rhGM-CSF for the treatment of late onset hemorrhagic cystitis after bone marrow transplant. Bone Marrow Transplant. 1999;24(12):1307–1310.
Crossref Google Scholar
39

Garg A, Dasgupta R, Shah S, et al. Role of intravesical granulocyte-macrophage colony-stimulating factor in controlling hemorrhagic cystitis in patients undergoing stem cell transplantation-A retrospective cohort study. Ind J Transplant. 2021;15(2):111
Crossref Google Scholar
40

Niu X, Xu X, Guo Z, et al. Granulocyte-macrophage colony stimulating factor bladder irrigation prevents hemorrhagic cystitis after hematopoietic stem cell transplantation. J Clin Rehabil Tissue Eng Res. 2009;13(27):5229–5233.
Google Scholar
41

Jiang Yi, Li J, Zhang J, et al. Efficacy of compound Kushen liquid combined with Chinese herbal enema in the treatment of radiation cystitis and enterocolitis. Chin J Inf Tradit Chin Med. 2011;18(10):70–71
Google Scholar
42

Zhang X, Wang W, Li M, et al. Clinical Study on Treatment of Radiogenic Cystitis after Radiotherapy of Cervical Cancer by Oral Administration of Xiaoji Yinzi Combined with Bladder Perfusion of Kangfuxin Liquid. Liaoning Journal of Traditional Chinese Medicine. 2021;48(11):96–99
Google Scholar
43

Xiong N, Hu Z, Guo H, et al. Experience of 16 cases of delayed-onset radiation cystitis treated with Chinese medicine. Journal Of Jiangxi College Of Traditional Chinese Medicine. 1999;11(3):103
Google Scholar
44

Alazem K, Cavallo JA, Vanni AJ. Radiation cystitis: a contemporary review. Curr Bladder Dysfunct Rep. 2019;14(4):246–255
Crossref Google Scholar
45

Villerirs L, Tailly T, Ost P, et al. Hyperbaric oxygen therapy for radiation cystitis after pelvic radiotherapy: systematic review of the recent literature. Int J Urol. 2020;27(2):98–107
Crossref Google Scholar
46

Oscarsson N, Muller B, Rosen A, et al. Radiation-induced cystitis treated with hyperbaric oxygen therapy (RICH-ART): a randomised, controlled, phase 2–3 trial. Lancet Oncol. 2019;20(11):1602–1614.
Crossref Google Scholar
47

Feldmeier JJ. Hyperbaric oxygen for radiation cystitis. Lancet Oncol. 2019;20(11):1481–1482.
Crossref Google Scholar
48

Piazza P, Rosiello G, Chacon VT, et al. Robot-assisted cystectomy with intracorporeal urinary diversion after pelvic irradiation for prostate cancer: technique and results from a single high-volume center. Europ Urol. 2021;80(4):489–496.
Crossref Google Scholar
49

Mangano MS, De Gobbi A, Ciaccia M, et al. Actinic cystitis: causes, treatment and experience of a single centre in the last five years. Urologia. 2018;85(1):25–28.
Crossref Google Scholar
50

Rodriguez-Patron Rodriguez R, Sanz Mayayo E, Gomez Garcia I, et al. Hypogastric artery embolization as a palliative treatment for bleeding secondary to intractable bladder or prostate disease. Arch Esp Urol. 2003;56(2):111–118.
Google Scholar
51

Fazili T, Bhat TR, Masood S, et al. Fate of the leftover bladder after supravesical urinary diversion for benign disease. J Urol. 2006;176(2):620–621.
Crossref Google Scholar
Precision Radiation Oncology
Volume 8 Issue 1,
May 2024
Pages 4-13
DOI: 10.1002/pro6.1215
Cite this article:
Wang W, Zhang F, Yuan S. Clinical Guidelines for the Prevention and Treatment of Radiation-induced Bladder Injury. Precision Radiation Oncology, 2024, 8(1): 4-13. https://doi.org/10.1002/pro6.1215

120

Views

0

Crossref

0

Scopus

Altmetrics
Received: 22 June 2023
Accepted: 16 November 2023
Published: 08 February 2024
© 2024 The Authors.

This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
Return